NLS PHARMACEUTICS LTD (NLSP)

CH0523961370 - Common Stock

0.18  +0.01 (+9.02%)

After market: 0.175 -0.01 (-2.78%)

Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to NLSP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.12. This target is 3300% above the current price.
NLSP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NLSP.
In the last month the buy percentage fell by 37 points. So the trust of analysts is decreasing.
NLSP was analyzed by 6 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 0.186.066.126.126.30 - 3,266.67% 3,300.00% 3,300.00% 3,400.00%
Up and Down Grades
Date Firm Action Rating
2023-09-14 Maxim Group Downgrade Buy -> Hold
2022-12-08 Maxim Group Upgrade Hold -> Buy
2022-11-08 Maxim Group Downgrade Buy -> Hold
2022-09-06 Laidlaw & Co. Initiate Buy
2021-03-12 Brookline Capital Initiate Buy
2021-03-03 Maxim Group Initiate Buy